CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.720
-0.200 (-5.10%)
At close: Mar 27, 2026, 4:00 PM EDT
3.740
+0.020 (0.54%)
After-hours: Mar 27, 2026, 4:10 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $34.44 million as of March 27, 2026. Its market cap has decreased by -27.93% in one year.
Market Cap
34.44M
Enterprise Value
13.58M
1-Year Change
-27.93%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $34.44M, a decrease of -20.39%. That is a compound annual growth rate of -8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 34.44M | -52.88% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 39.28M |
| Atara Biotherapeutics | 38.52M |
| LeonaBio | 38.18M |
| Apollomics | 37.84M |
| Palatin Technologies | 36.24M |
| NextCure | 36.07M |
| Veru Inc. | 35.79M |
| Rein Therapeutics | 35.61M |